{"id":"W4226000077","doi":"10.1007/s40120-022-00343-x","title":"Pharmacokinetics of XEN496, a Novel Pediatric Formulation of Ezogabine, Under Fed and Fasted Conditions: A Phase 1 Trial","year":2022,"lang":"en","type":"article","venue":"Neurology and Therapy","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Pharmacokinetics; Medicine; Neurology; Pharmacology; Phase (matter); Internal medicine; Chemistry; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001402834,0.00006359111,0.0001865786,0.00006204514,0.00009662441,0.000001833192,0.00002326138,0.00003150761,0.0002402263],"category_scores_gemma":[0.00002667502,0.0000534589,0.00002801534,0.0001241576,0.00006294532,0.00003491145,0.00003076986,0.0001729102,1.364567e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000001922126,"about_ca_system_score_gemma":0.00001738487,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000798679,"about_ca_topic_score_gemma":4.436353e-7,"domain_scores_codex":[0.9994555,0.00007590598,0.0001785248,0.0001118782,0.00009422592,0.00008393996],"domain_scores_gemma":[0.9994255,0.0003284909,0.0001253349,0.00005090678,0.00003257891,0.00003713616],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6803805,0.007343655,0.02386598,0.0002210582,0.0008475655,0.00003537433,0.001098962,0.0001189947,0.2526602,0.004451388,0.0008595441,0.02811677],"study_design_scores_gemma":[0.7626103,0.05349468,0.08270554,0.000005548908,0.001284912,0.0003202626,0.0002310299,0.01001656,0.006917053,0.002955128,0.07912154,0.0003374749],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945795,0.002070046,0.00006370278,0.002575134,0.0001327994,0.0003913931,0.00004362642,0.00000830421,0.0001355162],"genre_scores_gemma":[0.9940649,0.004033662,0.00002066341,0.001744617,0.00007817055,0.00002560705,0.00001337043,0.000005597313,0.00001341337],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2457432,"threshold_uncertainty_score":0.2630309,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08842120990572219,"score_gpt":0.4061781007746421,"score_spread":0.3177568908689199,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}